おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
APTBIO
company
About
APTBIO is a proteomic technology firm.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $28.29M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2004
- Number Of Employee
- 51 - 100
- Operating Status
- Active
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$28.29M
APTBIO has raised a total of
$28.29M
in funding over 2 rounds. Their latest funding was raised on
Apr 23, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 23, 2020 | Series A | $28.29M | 2 |
Wuxi New District Investment Group
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
APTBIO is funded by 2 investors.
Wuxi New District Investment Group
and Funway Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Wuxi New District Investment Group
|
Yes | Series A |
Funway Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
